These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28808762)

  • 1. Relationships between more than 90% coronary luminal narrowing induced by ergonovine provocation test and ECG ischemic change as well as chest symptoms.
    Sueda S; Kohno H
    Heart Vessels; 2018 Feb; 33(2):95-101. PubMed ID: 28808762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete definite positive spasm on acetylcholine spasm provocation tests: comparison of clinical positive spasm.
    Sueda S; Miyoshi T; Sasaki Y; Ohshima K; Sakaue T; Habara H; Kohno H
    Heart Vessels; 2016 Feb; 31(2):143-51. PubMed ID: 25366988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Heart Vessels; 2016 Mar; 31(3):322-9. PubMed ID: 25539623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Coron Artery Dis; 2015 Sep; 26(6):490-4. PubMed ID: 25974266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Heart Vessels; 2016 Feb; 31(2):137-42. PubMed ID: 25366987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Incidence and Morphology of Spasm According to Coronary Arterial Location by Intracoronary Ergonovine Spasm Provocation Testing.
    Sueda S; Kohno H
    Circ J; 2017 May; 81(6):831-836. PubMed ID: 28331112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pharmacological spasm provocation test in patients with a history of syncope.
    Sueda S; Kohno H
    Heart Vessels; 2018 Feb; 33(2):126-133. PubMed ID: 28905210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intracoronary administration of ergonovine on the contralateral coronary artery in a provocation test for the diagnosis of variant angina.
    Kim JH; Kim C; Kim J; Park JS; Lee HW; Choi JH; Lee HC; Cha KS; Hong TJ; Oh JH
    Acta Cardiol; 2014 Dec; 69(6):628-34. PubMed ID: 25643433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary ergonovine testing among 505 consecutive Japanese patients with angina-like chest pain and unobstructed coronary artery disease.
    Sueda S; Sakaue T
    Heart Vessels; 2022 Jun; 37(6):931-941. PubMed ID: 35059807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of epicardial adipose tissue volume quantified by non-contrast electrocardiogram-gated computed tomography on ergonovine-induced epicardial coronary artery spasm.
    Ito T; Fujita H; Ichihashi T; Ohte N
    Int J Cardiol; 2016 Oct; 221():877-80. PubMed ID: 27434364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.
    Sueda S; Fujimoto K; Sasaki Y; Sakaue T; Yoshii T; Habara H; Kohno H
    Heart Vessels; 2019 May; 34(5):745-754. PubMed ID: 30474702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events.
    Sueda S
    Heart Vessels; 2020 Oct; 35(10):1368-1377. PubMed ID: 32350639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adjunctive intracoronary administration of acetylcholine following intravenous infusion of ergonovine to provoke coronary artery spasm.
    Goto A; Ito S; Kondo H; Nomura Y; Yasue N; Suzumura H; Takeda Y; Tomimoto S; Yamada Y; Horio T; Suzuki S; Fukutomi T; Itoh M
    J Cardiol; 1999 Dec; 34(6):309-16. PubMed ID: 10642927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.
    Sueda S; Ochi T; Yano K; Mineoi K; Kondou T; Ochi N; Hayashi Y; Kukita H; Matsuda S; Kawada H; Tsuruoka T; Uraoka T
    Jpn Circ J; 2000 Aug; 64(8):559-65. PubMed ID: 10952150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ergonovine-echo test to assess the significance of chest pain at rest without ECG changes.
    Morales MA; Lombardi M; Distante A; Carpeggiani C; Reisenhofer B; L'Abbate A
    Eur Heart J; 1995 Oct; 16(10):1361-6. PubMed ID: 8746904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine spasm provocation test by trans-radial artery and brachial vein approach.
    Sueda S; Fujimoto K; Sasaki Y; Sakaue T; Habara H; Kohno H
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):38-44. PubMed ID: 30548131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.
    Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2017 Jun; 32(6):685-689. PubMed ID: 27873006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Usefulness of Intracoronary Acetylcholine 200 μg Into the Left Coronary Artery as Vasoreactivity Testing: Comparisons With Intracoronary Acetylcholine Maximum 100 μg.
    Sueda S; Hayashi Y; Ono H; Sakaue T; Ikeda S
    Clin Cardiol; 2024 Oct; 47(10):e70001. PubMed ID: 39355891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.